New shot aims to stop agony of gout flares
NCT ID NCT07453004
Summary
This study is testing an experimental drug called punarlimab to see if it can reduce the severe joint pain of an acute gout attack. It will involve about 170 adults who have frequent, painful gout flares and cannot take or do not get enough relief from common gout medicines. Researchers will compare punarlimab against an existing steroid treatment to see which is better at easing pain over 72 hours.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GOUTY ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.